These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6184169)

  • 21. Effect of PSK on interferon production in tumor-bearing mice.
    Kitani H; Tsuru S; Oguchi M; Watanabe M; Zinnaka Y
    J Clin Lab Immunol; 1984 Dec; 15(4):211-4. PubMed ID: 6084715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on the immunological response in rats with experimental urinary bladder carcinoma (author's transl)].
    Nishijima T
    Nihon Hinyokika Gakkai Zasshi; 1978 Aug; 69(8):1044-54. PubMed ID: 713203
    [No Abstract]   [Full Text] [Related]  

  • 23. Suppressive effect of interferon-beta on development of tumoricidal activity in mouse macrophages.
    Pace JL; MacKay RJ; Hayes MP
    J Leukoc Biol; 1987 Mar; 41(3):257-63. PubMed ID: 3104517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role for the macrophage in in vivo and in vitro resistance to murine bladder tumor cell growth.
    Droller MJ; Remington JS
    Cancer Res; 1975 Jan; 35(1):49-53. PubMed ID: 1109796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ability of cancer patients' macrophages to kill autologous tumor targets. Effect of prostaglandin inhibitors on cytotoxicity.
    Cameron DJ; Rittenbury M; Majeski J
    Cancer; 1984 May; 53(10):2053-7. PubMed ID: 6704892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
    Fujii T; Igarashi T; Kishimoto S
    J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of macrophages in suppression of established Friend virus leukemia.
    Levy MH; Wheelock EF
    J Reticuloendothel Soc; 1976 Sep; 20(3):243-54. PubMed ID: 1068297
    [No Abstract]   [Full Text] [Related]  

  • 28. The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers.
    Talmadge JE; Herberman RB
    Cancer Treat Rep; 1986 Jan; 70(1):171-82. PubMed ID: 3510733
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of the recreational agent isobutyl nitrite on human peripheral blood leukocytes and on in vitro interferon production.
    Hersh EM; Reuben JM; Bogerd H; Rosenblum M; Bielski M; Mansell PW; Rios A; Newell GR; Sonnenfeld G
    Cancer Res; 1983 Mar; 43(3):1365-71. PubMed ID: 6186374
    [No Abstract]   [Full Text] [Related]  

  • 30. Stimulatory effects of vitamin A analogs on induction of cell-mediated cytotoxicity in vivo.
    Lotan R; Dennert G
    Cancer Res; 1979 Jan; 39(1):55-8. PubMed ID: 761198
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of the cellular immune response during tumor development in an animal model of bladder cancer.
    Droller MJ; Gomolka D
    J Urol; 1982 Dec; 128(6):1385-9. PubMed ID: 7154212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential suppression by actinomycin D of interferon production and cellular resistance induced by Poly I:C.
    Vilcek J; Varacalli F
    J Gen Virol; 1971 Oct; 13(1):185-8. PubMed ID: 4331811
    [No Abstract]   [Full Text] [Related]  

  • 33. A possible mechanism of tumor regression in cisplatin-treated mice.
    Sarna S; Sodhi A; Bhola RK
    Pol J Pharmacol Pharm; 1989; 41(1):69-76. PubMed ID: 2587438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCG induced murine peritoneal exudate cells: cytotoxic activity against a syngeneic bladder tumor cell line.
    Pang AS; Morales A
    J Urol; 1982 Jun; 127(6):1225-9. PubMed ID: 7087042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variable response of human cells to polyinosinic-polycytidylic acid.
    Sreevalsan T
    Antimicrob Agents Chemother; 1973 May; 3(5):642-4. PubMed ID: 4790615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase inhibitors modulate NK activities that control metastatic disease.
    Kundu N; Walser TC; Ma X; Fulton AM
    Cancer Immunol Immunother; 2005 Oct; 54(10):981-7. PubMed ID: 15891886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poly I:C activated macrophages are tumoricidal for TNF-alpha-resistant 3LL tumor cells.
    Remels L; Fransen L; Huygen K; De Baetselier P
    J Immunol; 1990 Jun; 144(11):4477-86. PubMed ID: 2111350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of murine macrophages in response to interferon inducers.
    Neumann C; Sorg C
    Immunobiology; 1981; 158(4):320-9. PubMed ID: 6165678
    [No Abstract]   [Full Text] [Related]  

  • 39. The influence of emetine on the induction of interferon by poly-I: poly-C in Swiss mice.
    Schellekens H; Huffmeyer JH; Van Griensven LJ
    J Gen Virol; 1975 Feb; 26(2):197-200. PubMed ID: 1113083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic cells induced in tumor-bearing rats by a streptococcus preparation (OK-432).
    Hojo H; Hashimoto Y
    Gan; 1981 Oct; 72(5):692-9. PubMed ID: 7327369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.